Accurate Wealth Management LLC trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 9.6% in the 1st quarter, HoldingsChannel.com reports. The fund owned 1,607 shares of the conglomerate’s stock after selling 171 shares during the quarter. Accurate Wealth Management LLC’s holdings in Danaher were worth $302,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of the business. Ayrshire Capital Management LLC lifted its stake in Danaher by 6.0% during the 1st quarter. Ayrshire Capital Management LLC now owns 33,057 shares of the conglomerate’s stock valued at $6,777,000 after acquiring an additional 1,864 shares during the period. GAMMA Investing LLC lifted its stake in Danaher by 22.2% during the 1st quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock valued at $1,871,000 after acquiring an additional 1,660 shares during the period. Pallas Capital Advisors LLC lifted its stake in Danaher by 41.3% during the 1st quarter. Pallas Capital Advisors LLC now owns 27,243 shares of the conglomerate’s stock valued at $5,585,000 after acquiring an additional 7,965 shares during the period. Farther Finance Advisors LLC increased its holdings in shares of Danaher by 12.0% during the 1st quarter. Farther Finance Advisors LLC now owns 8,719 shares of the conglomerate’s stock valued at $1,747,000 after purchasing an additional 935 shares in the last quarter. Finally, City Holding Co. increased its holdings in shares of Danaher by 2.1% during the 1st quarter. City Holding Co. now owns 10,268 shares of the conglomerate’s stock valued at $2,105,000 after purchasing an additional 211 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Danaher
In other news, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares of the company’s stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company’s stock.
Danaher Price Performance
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. On average, equities analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.63%. Danaher’s payout ratio is 24.85%.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on the stock. Bank of America cut their target price on shares of Danaher from $265.00 to $230.00 in a report on Monday, April 14th. Wells Fargo & Company cut their target price on shares of Danaher from $240.00 to $210.00 and set an “equal weight” rating for the company in a report on Wednesday, April 23rd. Guggenheim reaffirmed a “buy” rating and set a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. The Goldman Sachs Group cut their target price on shares of Danaher from $260.00 to $240.00 and set a “neutral” rating for the company in a report on Wednesday, April 23rd. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $248.17.
View Our Latest Analysis on DHR
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is Consumer Discretionary a Dead End? These 3 Stocks Say No
- Where to Find Earnings Call Transcripts
- Why a Trump-Musk Feud Could Mean Big Wins for AST SpaceMobile
- 3 Dividend Kings To Consider
- Nintendo Stock Near Highs—Will the Switch 2 Keep the Rally Alive?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.